Table 1.9c

Immunosuppression Use by Organ

Maintenance Regimen at One Year Following Transplantation

2006 Transplants

		Organ
		Heart-Lung	Heart	Intestine	Kidney	KP	Liver	Lung	PAK	PTA
Transplants		31	2,193	175	17,091	924	6,650	1,406	293	173
With Maintenance Use Recorded at 1 Year PostTx		20	1,879	120	15,092	803	5,245	1,141	218	122
Maintenance Regimen	CyA	0.0%	0.3%	0.8%	0.2%	0.1%	1.9%	0.2%	0.0%	0.0%
	Tac	0.0%	2.8%	33.3%	2.6%	2.0%	26.6%	0.2%	1.8%	16.4%
	--- + MMF/MPA	0.0%	0.4%	0.0%	0.3%	0.4%	0.4%	0.2%	0.0%	0.8%
	CyA + MMF/MPA	0.0%	6.8%	0.0%	1.8%	0.4%	3.0%	0.2%	1.4%	0.8%
	Tac + MMF/MPA	0.0%	16.3%	0.0%	24.1%	18.9%	22.0%	1.2%	19.3%	13.1%
	--- + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
	CyA + OtherAntimet	0.0%	1.1%	0.0%	0.0%	0.1%	0.0%	0.1%	0.0%	0.0%
	Tac + OtherAntimet	0.0%	1.2%	0.0%	0.4%	0.1%	0.2%	0.2%	0.0%	0.0%
	--- + MMF/MPA + OtherAntimet	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	CyA + MMF/MPA + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Tac + MMF/MPA + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%
	--- + Siro/Evero	0.0%	0.0%	0.8%	0.2%	0.0%	1.9%	0.0%	0.0%	0.0%
	CyA + Siro/Evero	0.0%	0.4%	0.0%	0.8%	2.4%	0.3%	0.1%	2.3%	0.8%
	Tac + Siro/Evero	0.0%	1.2%	3.3%	1.2%	3.4%	1.2%	0.1%	4.6%	6.6%
	--- + MMF/MPA + Siro/Evero	0.0%	0.5%	0.0%	2.0%	1.0%	2.2%	0.0%	1.4%	0.0%
	CyA + MMF/MPA + Siro/Evero	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Tac + MMF/MPA + Siro/Evero	0.0%	0.5%	0.8%	0.5%	3.2%	0.2%	0.1%	1.8%	11.5%
	--- + OtherAntimet + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	CyA + OtherAntimet + Siro/Evero	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Tac + OtherAntimet + Siro/Evero	0.0%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.8%
	--- + Steroids	0.0%	0.2%	0.0%	0.3%	0.4%	0.2%	0.5%	0.0%	0.0%
	CyA + Steroids	0.0%	1.2%	0.8%	0.4%	0.2%	1.2%	1.5%	0.0%	0.0%
	Tac + Steroids	15.0%	2.7%	46.7%	4.2%	3.7%	15.0%	8.5%	3.7%	24.6%
	--- + MMF/MPA + Steroids	0.0%	0.4%	0.0%	1.3%	0.4%	0.5%	0.5%	1.8%	0.0%
	CyA + MMF/MPA + Steroids	0.0%	18.6%	0.0%	6.5%	2.0%	1.5%	4.1%	2.8%	0.0%
	Tac + MMF/MPA + Steroids	60.0%	35.4%	5.0%	44.0%	53.5%	17.4%	47.5%	50.9%	21.3%
	--- + OtherAntimet + Steroids	5.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.5%	0.5%	0.0%
	CyA + OtherAntimet + Steroids	5.0%	1.1%	0.0%	0.2%	0.0%	0.0%	4.6%	0.0%	0.0%
	Tac + OtherAntimet + Steroids	10.0%	1.5%	0.8%	1.1%	1.2%	0.2%	22.0%	1.8%	0.0%
	--- + Siro/Evero + Steroids	0.0%	0.3%	0.0%	0.4%	0.1%	1.1%	0.1%	0.5%	0.0%
	CyA + Siro/Evero + Steroids	0.0%	2.1%	0.0%	1.0%	0.6%	0.0%	0.4%	0.5%	0.8%
	Tac + Siro/Evero + Steroids	0.0%	1.5%	7.5%	1.7%	3.1%	0.9%	3.4%	3.7%	0.8%
	Other Regimen	5.0%	3.5%	0.0%	4.6%	2.4%	1.8%	3.8%	1.4%	1.6%

Source: OPTN/SRTR Data as of May 1, 2008.

Percentages are calculated based on the total number of patients with functioning graft and having any immunosuppression information reported at 1yr post-transplant.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF/MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.